February 2020 Briefing – Psychiatry
Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for February 2020. This roundup includes the latest...
Varenicline Seems Safe for Adults Without Depression
Risk for CV, neuropsychiatric hospitalizations lower for varenicline versus nicotine replacement therapy
Video Game-Like Intervention May Aid Children With ADHD
Attentional functioning improved in four-week trial for children receiving intervention versus control
NIH Toolbox Cognitive Battery Valid in Intellectual Disability
NIHTB-CB is reliable and valid for children and young adults with a mental age older than 5.0 years
Influence of Politics Has Not Waned in Opinions About ACA
Partisan divisions in favorable opinion of the ACA have gotten larger rather than smaller over time
No Compensatory Smoking Seen With Low-Nicotine Cigarettes
Two studies show no increase in smoking intensity, no increase in cigarettes smoked per day
Long-Term Antidepressant Use Appears to Raise Risk for T2DM
Study suggests glucose tolerance improves with antidepressant discontinuation or dose reduction
Medication Treatment May Lower Risk for Opioid Overdose Death
But protective effect during care does not last after discontinuation of treatment for opioid use disorder
USPSTF: Evidence Lacking for Cognitive Impairment Screening
Evidence lacking for screening for community-dwelling older adults with no signs or symptoms
Mistreatment, Discrimination Still Common for Medical Students
Women, racial/ethnic minorities, sexual minorities experience disproportionate mistreatment
